- Noticias y Estudios analíticos
- CBONDS OLD
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company primary areas of focus include HIV, AIDS, liver disease, and serious cardiovascular and respiratory conditions.
|10/01/2022||S&P Global Ratings affirms Gilead Sciences at "BBB+" (Local Currency LT credit rating); outlook negative|
|10/01/2022||S&P Global Ratings affirms Gilead Sciences at "BBB+" (Foreign Currency LT credit rating); outlook negative|
|05/01/2022||Gilead Sciences: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers|
|14/10/2021||Gilead Sciences to Release Third Quarter 2021 Financial Results on Thursday, October 28, 2021|
|15/07/2021||Gilead Sciences to Release Second Quarter 2021 Financial Results on Thursday, July 29, 2021|